# Bioequivalence Trial of a New Opioid Combination Compared to Reference

> **NCT00460785** · PHASE1 · COMPLETED · sponsor: **Grünenthal GmbH** · enrollment: 32 (—)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Opioid

## Key facts

- **NCT ID:** NCT00460785
- **Lead sponsor:** Grünenthal GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** —
- **Final completion:** 2007-03
- **Target enrollment:** 32 (—)
- **Last updated:** 2007-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00460785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00460785, "Bioequivalence Trial of a New Opioid Combination Compared to Reference". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT00460785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*